Hipoglucemia

Metabolism and nutrition disorders MedDRA 10020993

Glucosa en sangre peligrosamente baja, el riesgo principal de la insulina, las sulfonilureas y las meglitinidas.

Related Side Effects

Other effects in the Metabolism and nutrition disorders category:

Hiperglucemia Hiperpotasemia Hipopotasemia

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.